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Carbonic anhydrase (CA) is a zinc enzyme that catalyzes the reversible
conversion of carbon dioxide to bicarbonate (hydrogen carbonate) and a
proton. CAs have been extensively investigated owing to their involvement in
numerous physiological and pathological processes. Currently, CA inhibitors
are widely used as antiglaucoma, anticancer and anti-obesity drugs and for the
treatment of neurological disorders. Recently, the potential use of CA inhibitors
to fight infections caused by protozoa, fungi and bacteria has emerged as a new
research direction. In this article, the cloning and kinetic characterization of the
-CA from Vibrio cholerae (VchCA) are reported. The X-ray crystal structure
of this new enzyme was solved at 1.9 A˚ resolution from a crystal that was
perfectly merohedrally twinned, revealing a tetrameric type II -CA with a
closed active site in which the zinc is tetrahedrally coordinated to Cys42, Asp44,
His98 and Cys101. The substrate bicarbonate was found bound in a noncatalytic
binding pocket close to the zinc ion, as reported for a few other -CAs, such as
those from Escherichia coli and Haemophilus influenzae. At pH 8.3, the enzyme
showed a significant catalytic activity for the physiological reaction of the
hydration of CO2 to bicarbonate and protons, with the following kinetic
parameters: a kcat of 3.34  105 s1 and a kcat/Km of 4.1  107 M1 s1. The new
enzyme, on the other hand, was poorly inhibited by acetazolamide (Ki of
4.5 mM). As this bacterial pathogen encodes at least three CAs, an -CA, a
-CA and a -CA, these enzymes probably play an important role in the life
cycle and pathogenicity of Vibrio, and it cannot be excluded that interference
with their activity may be exploited therapeutically to obtain antibiotics with a
different mechanism of action.
1. Introduction
Vibrio cholerae is a Gram-negative bacterium found in coastal
waters and estuaries that causes cholera, an acute, secretory
diarrhoea. Cholera is endemic in over 50 countries and also
causes large epidemics, which have recently been increasing in
intensity, duration and frequency. Significant antibiotic resis-
tance to V. cholerae infection has also been reported (Harris et
al., 2012).
Carbonic anhydrases (carbonate hydrolyases; CAs; EC
4.2.1.1) are metalloenzymes that catalyze the interconversion
of CO2 and bicarbonate (for reviews, see Aggarwal, Boone
et al., 2013; Aggarwal, Kondeti et al., 2013; Supuran, 2012;
Capasso & Supuran, 2015). These enzymes are involved in
many physiological processes in microorganisms, such as
photosynthesis, respiration and CO2 transport, as well as the
metabolism of xenobiotics. Recently, CAs have been cloned
and characterized in many pathogenic and nonpathogenic
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bacteria in the search for antibiotics with a novel mechanism
of action. It has been demonstrated that CAs are essential
for the life cycle of the microorganism and that the conversion
of CO2 to bicarbonate plays a role in virulence-gene induction
(Capasso & Supuran, 2013). Bicarbonate in fact induces the
expression of the major V. cholerae virulence factors by
enhancing the activity of ToxT, a regulatory protein that
directly activates the transcription of the genes encoding the
cholera toxin. This is the first example of a positive effector of
ToxT activity, and bicarbonate is likely to be an important in
vivo signal that induces V. cholerae virulence-gene expression
during infection (Abuaita &Withey, 2009). V. cholerae utilizes
the CA system to accumulate bicarbonate in its cells,
suggesting a pivotal role of these metalloenzymes in microbial
virulence.
Three putative carbonic anhydrases are encoded by the
V. cholerae bacterium. They belong to three distinct classes: an
-CA, a -CA and a -CA (Heidelberg et al., 2000). Generally,
bacterial genomes only encode CAs belonging to the -CAs,
-CAS and -CAs. A total of six genetic families of CAs have
been discovered to date: -CAs, -CAs, -CAs, -CAs, -CAs
and -CAs. Most of them are zinc enzymes, although the  and
 classes can have iron(II) or cadmium(II), respectively, in the
active site (Lehneck & Po¨ggeler, 2014).
The -CA class is broadly distributed in nature, including
bacteria, algae, plant chloroplasts and invertebrates (Rowlett,
2010). To date, the crystallographic structures of -CAs from
Pisum sativum (Kimber & Pai, 2000), the red alga Porphyr-
idium purpureum (Mitsuhashi et al., 2000), Methanobacterium
thermoautotrophicum (Strop et al., 2001), Escherichia coli
(Cronk et al., 2001), Mycobacterium tuberculosis Rv1284 and
Rv3588c (Covarrubias et al., 2005), Haemophilus influenzae
(Cronk et al., 2006), Halothiobacillus neapolitanus (Sawaya et
al., 2006), the green alga Coccomyxa (Huang et al., 2011),
Sordaria macrospora (Lehneck et al., 2014) and Pseudomonas
aeruginosa (Pinard et al., 2015) have been published. The
biological unit of the structurally characterized -CAs appears
to be a dimer, a tetramer or an octamer, although the preva-
lent arrangement seems to be a tetramer or pseudotetramer
composed of two pseudo-dimers (P. purpureum and
H. neapolitanus -CAs).
Most of the kinetic properties observed for the -CAs are
consistent with a catalytic mechanism similar to the well
established ping-pong mechanism utilized by the -CAs, in
which the catalytically active entity is a zinc-bound water
molecule, which ionizes to a hydroxide ion. The first stage of
the proposed mechanism involves nucleophilic attack on CO2
by the zinc-bound hydroxide and the exchange of water for
bicarbonate at the zinc ion. The second stage is proton transfer
from the zinc-bound water to the bulk buffer to regenerate the
zinc-bound hydroxide ion. Most of the 15 human CA isoforms
known to date have a His residue at position 64 which is
actively involved in the proton shuttle and is responsible for
converting the zinc-bound water molecule to hydroxide ion. In
-CAs one or more intramolecular acceptors could play the
same role. For example, it has been demonstrated that in
-carbonic anhydrase from Arabidopsis thaliana residues
His216 and Tyr212 are both important for efficient proton
transfer. Tyr212 (Tyr83 in -CA from V. cholerae) is strictly
conserved in the -CAs from the Vibrio genus and in other
bacterial enzymes (Rowlett et al., 2002).
X-ray crystallographic analysis of -CAs revealed two
distinct subtypes of this enzyme class based on active-site
organization, denoted type I and type II -CAs. In the
enzymes from P. sativum, M. thermoautotrophicum and
M. tuberculosis Rv1284, the active-site zinc ion is coordinated
by one histidine and two cysteine residues, with a fourth
coordination site occupied by water or a substrate analogue
(the so-called open conformation). In contrast, the other
subclass of -CAs, exemplified by the structures of the
enzymes from H. influenzae, E. coli, P. purpureum and
M. tuberculosis Rv3588c, has a unique zinc-coordination
geometry in which the water molecule has been replaced by an
aspartate side chain, forming a noncanonical CA active site
(the closed conformation). The latter group of CAs (type II
-CAs) are characterized by little or no CO2 hydration activity
at pH values less than 8.0, compared with the former group
(type I -CAs) that shows catalytic activity at pH values from
as low as 6.5 to greater than 9.0. Type II -CAs also show
highly cooperative pH-rate profiles and cooperative inhibition
by HCO3
, whereas type I -CAs are not inhibited by HCO3

(Rowlett, 2010).
Therefore, it has been hypothesized that the closed
conformation observed in the structures of type II -CAs is an
allosteric form of the enzyme, the so-called T state, that is an
inactive form present at pH values below 8.0. This confor-
mation is stabilized by the presence of HCO3
, which was
found to bind in a noncatalytic site in E. coli and H. influenzae
-CAs (Cronk et al., 20068). However, at pH values of >8.3
the closed active site is converted to an open one, with an
incoming water molecule replacing the carboxylate moiety of
the Asp residue and thus generating the nucleophile used
in the catalytic cycle. This has been demonstrated by X-ray
crystallography (and kinetic studies) in an elegant work by
Jones and coworkers (Covarrubias et al., 2005). Indeed, at this
pH value the carboxylate of the Asp makes a strong inter-
action with the guanidine/guanidinium moiety of a conserved
Arg residue present in all -CAs so far investigated (Covar-
rubias et al., 2005).
Here, we report the kinetic characterization and the crystal
structure of the recombinant type II -CA from V. cholerae
determined at a resolution of 1.9 A˚ with a closed active-site
configuration.
2. Materials and methods
2.1. Gene identification
The identification of the gene encoding V. cholerae -CA
(VchCA) was performed using the NCBI Genome resource
(http://www.ncbi.nlm.nih.gov/genome/) selecting the genome
of V. cholerae. The -CA gene of V. cholerae was identified
by running BLAST using the -CA nucleotide sequence from
Brucella suis as the query sequence. The BLAST output file
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identified the VchCA sequence, with accession No.
WP_002051193.1.
2.2. Construct preparation, protein expression and
purification
The GeneArt company, which specializes in gene synthesis,
designed the synthetic V. cholerae gene encoding -CA and
containing four base-pair sequences (CACC) necessary for
directional cloning at the 50 end of the VchCA gene. The
fragment was subsequently cloned into the expression vector
pET100/D-TOPO (Invitrogen), creating the plasmid pET-100/
D-TOPO/VchCA. In order to confirm the integrity of the
V. cholerae gene and the fact that no errors occurred at the
ligation sites, the vector containing the fragment was
sequenced. Competent E. coli BL21 (DE3) cells were trans-
formed with pET-100/D-TOPO/VchCA, grown at 37C,
induced with 1 mM IPTG and grown for 4 h. After growth for
an additional 4 h, the cells were harvested and disrupted
by sonication at 4C in 20 mM phosphate buffer pH 8.0.
Following sonication, the sample was centrifuged at 12000g at
4C for 30 min. The supernatant was loaded onto a His-Select
HF nickel-affinity column (1.0  1.0 cm; GE Healthcare) and
the column was equilibrated with 0.02M phosphate buffer pH
8.0 containing 0.02M imidazole and 0.5M NaCl at a flow rate
of 1.0 ml min1. The VchCA was eluted with 0.02M phos-
phate buffer pH 8.0 containing 250 mM imidazole and 0.5M
NaCl at a flow rate of 1.0 ml min1. Fractions were collected,
dialyzed and analyzed by SDS–PAGE (data not shown).
At this stage of purification the enzyme was at least 95% pure
and the yield obtained was 30 mg of recombinant bacterial
VchCA.
2.3. Kinetics methods
An Applied Photophysics stopped-flow instrument was
used to assay the CA-catalyzed CO2 hydration activity
(Khalifah, 1971). Bromothymol blue (at a concentration of
0.2 mM) was used as an indicator, working at an absorbance
maximum of 557 nm, with 10–20 mM Tris pH 8.3 as buffer and
20 mM Na2SO4 to maintain the ionic strength at a constant
value (this anion is not inhibitory and has a Ki of >200 mM
against this enzyme), following the initial rates of the CA-
catalyzed CO2 hydration reaction for a period of 10–100 s at
25C. The CO2 concentration ranged from 1.7 to 17 mM for
the determination of the kinetic parameters and inhibition
constants. For each measurement, at least six traces of the
initial 5–10% of the reaction were used to determine the initial
velocity. Typically, the first 10 s of the traces were used to
determine the initial rate, which was performed by linear
fitting using a program provided by Applied Photophysics.
The CO2 concentrations ranged from 1.7 to 17 mM for
determination of the kinetic parameters and inhibition
constants. The uncatalyzed rates (which needed times of
around 30 s in our assay conditions) were determined in the
same manner and were subtracted from the total observed
rates. Stock solutions of inhibitor (1–10 mM) were prepared in
distilled deionized water and dilutions of up to 0.01 mM were
then made with distilled deionized water. Inhibitor and
enzyme solutions were pre-incubated together for 15 min at
room temperature prior to the assay in order to allow the
formation of the E–I complex. The inhibition constants were
obtained by nonlinear least-squares methods using the
Cheng–Prusoff equation, whereas the kinetic parameters for
the uninhibited enzymes were obtained from Lineweaver–
Burk plots (Del Prete, De Luca, Vullo et al., 2014; Del Prete et
al., 2015; Maresca et al., 2013), as reported previously, and
represent the mean of at least three different determinations.
The enzyme concentrations at which the measurements were
performed were of the order of 9.3–15.6 nM. In these condi-






where IC50 represents the molarity of inhibitor that reduces
the enzyme activity by 50% (determined using eight different
concentrations of inhibitor varying between 0.1 nM and
150 mM), Km is the concentration of the substrate at which
the enzyme activity is half of the maximum and [S] is the
concentration of substrate.
2.4. Crystallization and data collection
The enzyme was crystallized at 296 K using the sitting-drop
vapour-diffusion method in 96-well plates (CrystalQuick,
Greiner Bio-One, Germany). Drops were prepared using 1 ml
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Table 1
Summary of data-collection and atomic model-refinement statistics.




Unit-cell parameters (A˚) a = 84.09, c = 316.38
Wavelength (A˚) 0.979
Limiting resolution (A˚) 47.5–1.9 (2.01–1.90)
Unique reflections 166608 (24184)
Rmerge (%) 7.9 (43.3)
Rmeas (%) 9.3 (56.3)
Multiplicity 3.3 (2.0)
Completeness (%) 96.8 (87.1)
hI/(I)i 10.82 (1.62)
CC1/2 (%) 99.6 (60.1)
Refinement
Resolution range (A˚) 30.0–1.90
Unique reflections, working/free 158223/8261




R.m.s.d., bonds (A˚) 0.008
R.m.s.d., angles () 1.289










protein solution mixed with 1 ml reservoir solution and were
equilibrated against 100 ml precipitant solution. The concen-
tration of the protein was 10 mg ml1 in 50 mM Tris pH 7.2.
Initial crystallization condition were found using the JCSG-
plus screen (Molecular Dimensions) and were optimized.
Diffraction-quality crystals grew within one week to approx-
imate dimensions of 0.2  0.2  0.3 mm from a solution
consisting of 8% PEG 8000, 8% ethylene glycol, 100 mM
HEPES pH 7.5. The crystals belonged to the primitive tetra-
gonal space group P41, with unit-cell parameters a = 84.09,
c = 316.38 A˚. The asymmetric unit contained two tetramers
(VM = 2.8 A˚
3 Da1, solvent content 56.1%) related by pseudo-
translational symmetry. A native data set extending to a
maximum resolution of 1.9 A˚ was collected on the BM30A
beamline at ESRF, Grenoble, France using a ADSC Quantum
315r detector and a wavelength of 0.979 A˚. For data collection
a crystal of the enzyme was cooled to 100 K using a solution
consisting of 15% PEG 8000, 15% ethylene glycol, 100 mM
HEPES pH 7.5 as cryoprotectant. The data were processed
with XDS (Kabsch, 2010).
2.5. Structure determination and refinement
The structure was solved by the molecular-replacement
technique using MOLREP (Vagin & Teplyakov, 2010) with
the coordinates of the structure of -carbonic anhydrase from
E. coli (PDB entry 2esf; Cronk et al., 2006) as a starting model.
The model was refined using REFMAC5 (Murshudov et al.,
2011) from the CCP4 suite (Winn et al., 2011). Manual
rebuilding of the model was performed using Coot (Emsley et
al., 2010). Solvent molecules were introduced automatically
using ARP/wARP (Lamzin et al., 2001). Refinement resulted
in R-factor and Rfree values of 0.183 and 0.238, respectively.
Data processing and refinement statistics are summarized in
Table 1. The stereochemistry of the final model was analyzed
with PROCHECK (Laskowski et al., 1993). The overall mean
B factor of the structure after refinement was 22.92 A˚2 for
water molecules and 22.49 A˚2 for all atoms. Protein coordi-
nates have been deposited in the Protein Data Bank (PDB
entry 5cxk). Structural figures were generated with the UCSF
Chimera package (Pettersen et al., 2004).
2.6. Merohedral twinning
The data set was initially processed in space group P422
with reasonable statistics (Rmerge = 8.3%). Molecular repla-
cement in space group P41212 provided a solution with a single
tetramer in the asymmetric unit, which was refined to an R
factor and Rfree of 0.23 and 0.27, respectively. Later it was
realised that the data had been collected from a crystal that
was almost perfectly merohedrally twinned. Thus, the data
were processed again in the lower symmetry tetragonal space
group.
A molecular-replacement solution was found in space group
P41 with two tetramers related by a pseudo-translation, which
was confirmed by a peak that was 20% of the origin peak at
(0.0, 0.15, 0.50) in the native Patterson map. No rotational
symmetry was detected in the self-rotation function in addi-
tion to that derived from the fourfold crystallographic axis
and the noncrystallographic 222 symmetry exhibited by one
tetramer subunit.
The possibility of twinning of the data was suggested by
analysis of the intensity distribution. The phenix.xtriage
module of PHENIX (Adams et al., 2002) was used to analyze
the data for twinning. The multivariate Z-score from the
L-test of PHENIX was well above the expected value of 3.5. A
high Z-score value indicates that the data differ significantly
from what is expected for untwinned data. The results of the
twinning tests and twinning law are shown in Supplementary
Table S1.
Thus, the twin-refinement option in REFMAC was used.
The R factor and Rfree decreased substantially at the stage in
which this option was introduced in the refinement. The
twinning fraction refined to a value of 0.49.
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Figure 1
(a) Ribbon diagram showing a single subunit of the VchCA structure.
The active-site zinc is also represented with its ligands. (b) Ribbon
diagram showing the tetrameric arrangement of VchCA.
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3. Results and discussion
3.1. X-ray structural investigation
The X-ray structure of VchCA was solved by molecular
replacement using the coordinates of the -CA from E. coli.
The enzyme crystallizes with four subunits in the asymmetric
unit. Analysis of the crystal contacts using the PISA software
(Krissinel & Henrick, 2007) suggested that the biologically
active molecule is a homotetramer possessing 222 symmetry.
The final model comprises the entire protein sequence, i.e.
residues 1–222, for every chain. Additionally, the model
includes eight zinc ions, six bicarbonate ions and 835 water
molecules (see Fig. 1).
Among the -CAs of known structure, the highest level of
sequence homology of VchCAwas found to the -CAs from
Salmonella enterica (63% identity), from E. coli (61% iden-
tity) and from H. influenzae (58% identity).
The X-ray structure of VchCA is similar to the structures
of the other -CAs mentioned above. The superposition of the
VchCA model with the -CAs from E. coli (PDB entry 2esf;
Cronk et al., 2006), S. enterica (PDB entry 3qy1; Center for
Structural Genomics of Infectious Diseases, unpublished
work) and H. influenzae (PDB entry 2a8d; Cronk et al., 2006)
yielded r.m.s.d.s between C atoms of 1.202, 1.371 and 1.435 A˚,
respectively (see Fig. 2). Each monomer adopted an / fold,
being composed of an N-terminal arm, which extends away
from the rest of the molecule and makes significant contacts
with an adjacent monomer, a conserved zinc-binding core and
a C-terminal domain dominated by -helices. The zinc-binding
core resembles the classical nucleotide-binding Rossmann-
fold motif (Rossmann et al., 1974) with a -sheet composed
of four parallel strands flanked on both sides by -helical
segments. The active site is located at one end of the central
-sheet at the interface of one dimer.
In the active site the zinc ion is coordinated to four amino-
acid residues, Cys42, Asp44, His98 and Cys101, with an
approximately tetrahedral geometry (Fig. 3). Therefore,
VchCA belongs to the type II subclass -CAs, which are
characterized by four protein-derived ligands that coordinate
the catalytic zinc ion, in contrast to the type I -CAs, which
have only two cysteine residues and one histidine residue in
the zinc-coordination sphere, with a fourth coordination site
occupied by a water molecule/hydroxide ion or a substrate
analogue/inhibitor (Rowlett, 2010). The zinc-bound Asp44
residue forms a Asp–Arg dyad in type I -CAs, whereas in
VchCA and in all other type II -CAs this dyad interaction
is broken so that Asp44 can freely coordinate the zinc while
Arg46 is rotated away. As shown by the excellent work of
Jones and coworkers (Covarrubias et al., 2005, 2006), at pH
values of >8 the COOH moiety of Asp44 and the guanidine
moiety of Arg46 interact with each other, forming a strong
interaction (salt-like or hydrogen bonds), which liberates the
fourth coordination position at the Zn2+ ion, which will
coordinate an incoming water molecule. This water molecule
is further activated by the Asp–Arg dyad (and the Zn2+ ion),
providing the nucleophile used by the enzyme in the catalytic
cycle (Supuran, 2012; Covarrubias et al., 2005, 2006).
An electron density that is not explainable by protein or
solvent atoms was present in the Fo  Fc maps near the active
site of six of the eight subunits (chains A, B, C, D, H and G).
This electron density has a triangular and planar shape and
was interpreted as a bicarbonate ion. The bicarbonate ion is
bound in a pocket at a distance of roughly 8 A˚ from the zinc
and forms hydrogen bonds to the side chains of Trp39, Arg64
and Tyr181 and to the peptide carbonyl of Val47. Each residue
donates one or more hydrogen bonds to the bicarbonate; in
addition, two water molecules also form multiple hydrogen
bonds to bicarbonate O atoms (see Fig. 4).
Since the bicarbonate cannot be derived either from the
purification or the crystallization process, it should be inter-
preted as an adventitious ligand. Nevertheless, kinetic studies
revealed that bicarbonate is an inhibitor as well as a substrate
research papers
Acta Cryst. (2015). D71, 2449–2456 Ferraroni et al.  Tetrameric type II -carbonic anhydrase 2453
Figure 2
Superposition of a monomer of VchCA (orange) with that of -CA
from E. coli (gold) and H. influenzae (light blue). The catalytic zinc ion is
represented as a magenta sphere.
Figure 3
Fo  Fc OMIT map (contoured at 3) of the active site of VchCA
exhibiting a ‘closed’ configuration.
electronic reprint
of H. influenzae -CA, and a bicarbonate ion bound in the
same position as in VchCA has previously been found in two
crystal structures: one of -CA from E. coli (PDB entry 2esf)
and another from H. influenzae (PDB entry 2a8d) (Cronk et
al., 2006). It is worth noting that in order to obtain these latter
structures the crystals were intentionally soaked in a solution
containing 100 mM NaHCO3 before data collection.
It has already been observed that the binding of the bicar-
bonate ion to this noncatalytic site enforces a closed confor-
mation of the active site in type II -CA structures. In fact
bicarbonate expels the side chain of Val47, which causes
reorganization of the 44–48 loop and results in the disruption
of the Asp44–Arg46 dyad, allowing Asp44 to displace the zinc-
bound water and bind directly to the zinc ion. This state has
been called the T state or inactive state, and it was previously
found to be present at acidic and neutral pH. However, the
alternative open configuration has not been observed in any
type II -CA structure, regardless of the crystallization pH
and the concentration of bicar-
bonate in the crystallization
medium, but the kinetic data
suggest that these enzymes adopt
this conformation in order to
function in a highly cooperative
manner. The active form can be
inferred from the crystal struc-
tures of type I -CAs in which
Asp44 is detached from the
catalytic zinc ion and is hydrogen-
bonded in a bidentate mode to
Arg46. Nevertheless, the active
form has been observed in two
mutants of H. influenzae (D44N
and P48S/A49P; Rowlett et al.,
2009; Hoffmann et al., 2015)
and in a thiocyanate inhibitor complex of M. tuberculosis
-CA (Covarrubias et al., 2006).
The presence of a triad of residues formed by Trp39, Tyr181
and Arg64 has previously been recognized as fundamental for
the binding of bicarbonate to the noncatalytic site and is
strictly conserved in type II -CAs. In contrast, the Trp–Arg–
Tyr triad is absent in all type I -CAs. Furthermore, the
noncatalytic bicarbonate-binding site seems to be especially
evolved for this particular ion, as other isoelectronic ions such
as acetate or nitrate would not be able to achieve all of the
hydrogen-bonding interactions in which bicarbonate partici-
pates simultaneously. Thus, our findings reinforce the
hypothesis that the bicarbonate binding to a noncatalytic site
near the zinc ion is a distinctive feature of type II -CAs and
plays a significant role in the functionality of this enzyme type.
3.2. Kinetic data
We have investigated the kinetic properties of VchCA as a
catalyst for the hydration of carbon dioxide to bicarbonate at
pH 8.3, when presumably the active site of the enzyme should
be in the open state, i.e. with water or hydroxide as the fourth
zinc ligand. Data are reported in Table 2, in which we have
included, for comparison, kinetic data for other - and -class
CAs of various origins, such as the bacterial CA from the same
pathogen belonging to the -class (VchCA; Del Prete, De
Luca, Scozzafava et al., 2014), but also the human main red
blood cell isoforms hCA I and II (Supuran, 2012; Khalifah,
1971), together with -CAs from various pathogens, such as
Can2 from the fungus Cryptococcus neoformans, CaNce103
from Candida albicans, psCA3 from the bacterium Pseudo-
monas aeruginosa (Supuran, 2012; Pinard et al., 2015) and
PgiCA from another bacterial pathogen, Porphyromonas
gingivalis (Del Prete, De Luca, Vullo et al., 2014). The CO2
hydration reaction was monitored with and without a catalyst
by a stopped-flow CO2 hydration assay at pH 7.5 for the
-CAs and at pH 8.3 for the -CAs. Inhibition data with the
clinically used sulfonamide acetazolamide are also given
(Khalifah, 1971).
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Table 2
Kinetic properties of the V. cholerae -class (VchCA) and -class (VchCA) CAs for the CO2 hydration
reaction determined by a stopped-flow CO2 hydrase assay and their inhibition data with the clinically used
sulfonamide acetazolamide (Khalifah, 1971).
Kinetic/inhibition data for other -class and -class CAs are given for comparison. The measurements were
performed at pH 7.5 for the -CAs and at pH 8.3 for the -CAs. Can2, C. neoformans -CA; CaNce103, C. albicans
-CA; psCA3, P. aeruginosa -CA, isoform 3 (Supuran, 2012; Pinard et al., 2015).






hCA I  2.0  105 5.0  107 250 Supuran (2012)
hCA II  1.4  106 1.5  108 12 Supuran (2012)
Can2  3.9  105 4.3  107 10.5 Supuran (2012)
CaNce103  8.0  105 9.7  107 132 Supuran (2012)
PgiCA  2.8  105 1.5  107 214 Del Prete, De Luca, Vullo et al. (2014)
psCA3  1.40  105 1.0  107 75.9 Pinard et al. (2015)
VchCA  8.23  105 7.0  107 6.8 Del Prete, De Luca, Scozzafava et al. (2014)
VchCA  3.34  105 4.1  107 4512 This work
Figure 4
The noncatalytic bicarbonate-binding site. A 2Fo  Fc electron-density
map (contoured at 1.5) is also shown. Hydrogen bonds formed by the
bicarbonate ions to enzyme residues and water molecules are also
depicted as dashed lines.
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The data in Table 2 show that
VchCA possesses a good catalytic
activity for the physiological reaction,
with kinetic parameters similar to those
of the slow human isoform hCA I or the
pathogenic enzymes from C. neofor-
mans (-class) or V. cholerae (-CA).
Indeed, with a kcat of 3.34  105 s1 and
a kcat/Km of 4.1  107 M1 s1, this
enzyme is much more efficient as a
catalyst compared with psCA3 and
PgiCA, only being less effective when
compared with hCA II (one of the
best catalysts known in nature) and
CaNce103 among the enzymes shown in
Table 2 (Del Prete, De Luca, Vullo et al.,
2014; Del Prete et al., 2015; Maresca et
al., 2013). However, unlike most of the
enzymes discussed above, VchCA was
only poorly inhibited by the classical
sulfonamide CA inhibitor used clini-
cally, acetazolamide, with an inhibition
constant of >4.5 mM (Table 2). It should
be noted that many of the CAs
discussed here are much more effec-
tively inhibited by this sulfonamide,
with Ki values ranging between 6.8 and
250 nM.
This good catalytic activity of
VchCA can of course be easily
explained considering the crystal-
lographic data presented above as well
as the alignment of various bacterial
-CAs shown in Fig. 5. Indeed, VchCA
possesses all of the conserved amino-
acid residues essential for catalysis, such
as, for example, the zinc(II) ligands
(Cys42, His98 and Cys101 in the open
active-site state) as well as the catalytic
dyad (Asp44-Arg46) present in all of these enzymes irre-
spective whether they belong to the type I or type II subclass.
4. Conclusions
The cloning, X-ray crystal data and kinetic characterization of
the -CA from V. cholerae (VchCA) are reported in this
paper. The X-ray crystal structure of the enzyme was solved at
1.9 A˚ resolution. VchCA was revealed to be a tetrameric
type II -CA with a closed active site in which the zinc is
tetrahedrally coordinated to Cys42, Asp44, His98 and Cys101
(the crystallization was performed at a pH of 7.5). Further-
more, the substrate bicarbonate was observed bound in each
monomer of VchCA in a noncatalytic binding pocket close to
the zinc ion, as reported for a few other -CAs, such as those
from E. coli andH. influenzae. At pH 8.3 the enzyme showed a
significant catalytic activity for the physiological reaction of
the hydration of CO2 to bicarbonate and protons, with the
following kinetic parameters: a kcat of 3.34 105 s1 and a kcat/
Km of 4.1  107 M1 s1. The new enzyme was, on the other
hand, poorly inhibited by acetazolamide (Ki of 4.5 mM). As
this bacterial pathogen encodes at least three CAs, an -CA, a
-CA and a -CA, these enzymes probably play important
roles in the life cycle and pathogenicity of Vibrio, and it cannot
be excluded that interference with their activity may be
exploited therapeutically to obtain antibiotics with a different
mechanism of action.
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